tiprankstipranks
Advertisement
Advertisement
AC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
PremiumRatingsAC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
23d ago
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
Premium
Company Announcements
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
26d ago
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
Premium
The Fly
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
26d ago
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
PremiumRatingsPromising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results
4M ago
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
Premium
The Fly
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results
4M ago
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
Premium
Company Announcements
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy
4M ago
AC Immune reduced workforce by around 30% following strategic review
PremiumThe FlyAC Immune reduced workforce by around 30% following strategic review
5M ago
AC Immune appoints Mummery as Chair of Clinical Advisory Board
Premium
The Fly
AC Immune appoints Mummery as Chair of Clinical Advisory Board
5M ago
AC Immune’s ACI-24.060 Study: A Potential Game-Changer in Alzheimer’s Treatment
Premium
Company Announcements
AC Immune’s ACI-24.060 Study: A Potential Game-Changer in Alzheimer’s Treatment
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100